All News

We are often far harsher on ourselves than we would be with others.

Learning to move forward after breast cancer is a choice many have a difficult time making.

At Bright Pink, we feel fortunate to hear stories each day from young women who are taking action when it matters most.

Four new drugs were approved in 2015 to treat multiple myeloma, and Sundar Jagannath is optimistic about the coming years.

A session at the 2016 National Comprehensive Cancer Network (NCCN) Annual Conference opened today with a spotlight on finding more effective ways to encourage and deliver palliative care services across a variety of settings in oncology.

We wouldn't have rainbows without rain.

Although there were no major changes to the 2016 update to the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines, there were some “tweaks.”

Although immunotherapies have been approved for use for patients with metastatic melanoma, doctors are still apprehensive to use them as a frontline treatment option.

Ed's awareness of the happenings around him created great admiration for nurses.

The treatment landscape of chronic lymphocytic leukemia is rapidly evolving, according to Jeffrey Jones, an assistant professor at The Ohio State University Comprehensive Cancer Center.

Balancing hope and fear? I can do that.

Learn from a cancer survivor who wasn't proud of how she handled cancer the first time.

If you’ve been through the cancer journey, you’ve most likely bumped into someone professing the benefits from whatever tools were a part of their recovery. The information and promises can be overwhelming, contradicting and confusing.

A cancer diagnosis can easily get you thinking how great it would be to be anyone else. I learned very quickly that this is a wish I hope never to have granted.

Things are looking up for Ed as he begins the third chemo cycle.

The landscape for treating CLL is changing, bringing about questions and hope for a cure.

The FDA's breakthrough designation is meant to expedite the development of therapies that offer substantial benefits over existing options.

As the number of HNC survivors continues to increase, the American Cancer Society issued new guidelines for patients and their physicians.

The “sugar is poison” ideology is wrong.

Life after cancer calls for yet another new normal.

In the midst of the approval of new treatments for colorectal cancer, Alan P. Venook wants to remind health care professionals not to forget the more traditional and established therapies.

Pain from chemotherapy-induced peripheral neuropathy may be able to be reduced using neurofeedback, according to a recent study.

CURE speaks with Joyce O’Shaughnessy, MD, on the rise of treatment options for patients with estrogen receptor (ER)-positive metastatic breast cancer.

Looking for the silver lining during cancer isn't always easy, but it is possible.

Several new tests for prostate cancer are on the market. When used alongside PSA screenings, they can provide a much more straightforward insight into prostate cancer risk.

According to a recent study, financial distress can affect a newly diagnosed patient's overall well-being and quality of life.

Long before we departed on our vacation, a pact was made. The island was declared a cancer-free zone.

A recent study showed that women being treated for gynecologic malignancies can reduce their need for opioids by receiving Exparel.